NBIX
Neurocrine Biosciences Inc ยท Health Care ยท NASDAQ
$161.62
โฒ $3.33 (+2.10%)
Market cap
$15.9B
52-week range
$122.14 โ $169.57
Volume
1.0M
Previous close
$158.29
Neurocrine Biosciences Inc (NBIX) is held by 3 tracked hedge fund(s). Sector: Health Care. Largest tracked holder: Renaissance Technologies.
| Fund | % of portfolio | Shares | Value | Latest activity | Avg buy price | Date |
|---|---|---|---|---|---|---|
| Renaissance Technologies Jim Simons |
0.5% | 2.2M | $318M | โผ 7.4% (โ180K) | $0.12 | 2025-12-31 |
| RTW INVESTMENTS, LP RTW INVESTMENTS, LP |
1.4% | 1.1M | $140M | โ | $125.69 | 2026-03-31 |
| ARMISTICE CAPITAL, LLC ARMISTICE CAPITAL, LLC |
1.7% | 724K | $95M | โผ 12% (โ96K) | $101.22 | 2026-03-31 |
FAQ โพ
Which hedge funds hold NBIX?
Tracked holders include: Renaissance Technologies, RTW INVESTMENTS, LP, ARMISTICE CAPITAL, LLC.
How much smart money owns NBIX?
3 tracked hedge fund(s) have disclosed positions.
Are members of Congress trading NBIX?
No tracked Congressional trades in NBIX on file.
Where does this data come from?
SEC 13F filings (funds), Form 4 (insiders) and STOCK Act reports (Congress).
Sourced from SEC 13F, Form 4 & STOCK Act filings ยท Not investment advice โพ
Ownership from SEC filings; price from market data.
Published by WealthFile ยท Not investment advice.